Engineered for immediate commercial scale, high active retention, and global regulatory compliance across 40+ destination markets.
From validated pilot plants to multi-site pharmaceutical-grade contract lines, we mitigate supply risks for high-growth dietary brands.
Headquartered in Mississauga, Canada, our central operations adhere strict Health Canada Site Licences and US FDA facility registrations. Every lot comes with full traceability, validated sanitation protocols, and audited chain-of-custody documentation.
To optimize logistics costs and mitigate tariff risks, we maintain qualified CDMO facilities across Canada, the United States, China, India, and the UAE. Seamlessly transition production between hubs to protect your supply chain from local disruptions.
In-house laboratories equipped with HPLC, ICP-MS (heavy metals), and GC-MS (residual solvents) perform thorough testing. Raw materials and finished goods are verified for identity, potency, and micro-purity prior to batch release.
Skip regulatory hurdles with our expert compliance team. We assemble Health Canada NPN submissions, US FDA Supplement Facts panels, EU Food Supplement Dossiers, and Middle East GCC registration files, ensuring smooth customs clearance globally.
We specialize in 12 distinct delivery formats including high-stability pectin gummies, nitrogen-flushed softgels, micro-encapsulated powders, bilayer tablets, HPMC vegan capsules, and liquid shots engineered for maximum bio-absorption.
Work directly with an assigned Project Lead who orchestrates scientists, quality assurance managers, and logistics specialists on your behalf—eliminating communication bottlenecks and keeping launch schedules intact.
The global dietary supplement landscape is undergoing a structural paradigm shift. Simple private label re-flagging is no longer enough to win market share on competitive channels like Amazon, clinical practitioner networks, or retail pharmacy shelves. Today's consumers demand target-specific efficacy, clean-label transparency, allergen isolation, and superior organoleptic profiles. For brand owners, achieving these metrics while maintaining healthy profit margins requires partnering with an advanced Original Design Manufacturer (ODM) capable of turning raw active research into market-ready, stable dosage forms.
One of the primary technical bottlenecks in nutraceutical ODM manufacturing is the degradation of delicate active compounds when exposed to ambient moisture, gastric acid, or oxidation. Modern contract formulation addresses these challenges through precision particle delivery engineering:
The transition from traditional compressed tablets and hard-shell capsules toward functional gummies has transformed from a niche consumer trend into a core procurement requirement. However, formulating functional gummies presents distinct chemical and physical hurdles compared to standard candy manufacturing:
| Technical Metric | High-Methoxyl (HM) Pectin Base | Traditional Gelatin Base | ODM Innovation Advantage |
|---|---|---|---|
| Thermal Stability | Stable up to 45°C (Will not melt in warm transit) | Melts at >32°C (Requires cold-chain transport) | Eliminates refrigerated shipping costs for DTC brands. |
| Dietary & Regulatory Fit | 100% Plant-Derived (Vegan, Halal, Kosher) | Animal-Derived (Porcine/Bovine restrictions) | Unlocks immediate entry to Middle East & EU vegan segments. |
| Active Loading Capacity | Moderate to High (up to 15% active mass) | Moderate (Risk of gel structure breakdown) | Custom sugar-free polyol matrices allow high-dose actives without sugar crystallization. |
| Active Release Profile | Clean, rapid dissolution in mouth & stomach | Elastic, slow enzymatic breakdown | Optimizes nutrient release rates for water-soluble vitamins. |
As regulatory scrutiny from bodies like Health Canada, the US FDA, and the European Food Safety Authority (EFSA) intensifies, corporate procurement teams must adapt their supplier evaluation criteria. Key structural trends reshaping procurement strategy include:
Relying on a single manufacturing plant in one geographic region exposes brands to trade tariffs, localized supply chain halts, and freight bottlenecks. Forward-thinking supplement enterprises are shifting toward contract manufacturers with dual-continent production licenses. Utilizing centralized Canadian R&D alongside qualified production nodes in North America, Asia, and the Middle East allows brands to dynamically shift batch runs based on shipping economics and import duty variations.
Launching a new stock keeping unit (SKU) historically required minimum commitments of 50,000 to 100,000 bottles, trapping significant working capital in unproven inventory. Modern ODM platforms overcome this barrier by providing pilot batch scaling—allowing brands to enter the market with initial production batches as low as 1,000 to 5,000 units for market testing, stability validation, and initial sales velocity checks before locking in large-scale production runs.
The era of self-certified Certificates of Analysis (COAs) is over. Modern buyers expect lot-specific analytical backing via independent ISO 17025 accredited testing facilities. Key baseline parameters required for international import clearing include:
Direct answers to technical, regulatory, and operational questions commonly raised by brand directors and supply chain managers.
Partner with a verified Canadian & Global CDMO. Speak directly with our formulation scientists and regulatory engineers to request sample kits or custom quotes within 24 hours.
